These drugs are targeted therapies that block specific molecules involved in inflammation, such as tumor necrosis factor (TNF), interleukins, or B cells. Examples include adalimumab, etanercept, and rituximab.
These drugs are targeted therapies that block specific molecules involved in inflammation, such as tumor necrosis factor (TNF), interleukins, or B cells. Examples include adalimumab, etanercept, and rituximab.